share_log

HC Wainwright & Co. Reiterates Neutral on Zymeworks, Maintains $8 Price Target

Benzinga ·  Jun 6, 2023 06:18

HC Wainwright & Co. analyst Robert Burns reiterates Zymeworks (NASDAQ:ZYME) with a Neutral and maintains $8 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment